Exclusive

Publication

Byline

Location

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, Aug. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate t... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More


Singapore Clinical Trial: A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy of MK-1084, Cetuximab, and mFOLFOX6 versus mFOLFOX6 With or Without Bevacizumab as First-line Treatment of Participants With KRAS G12C-mutant, Locally Advanced Unresectable or Metastatic Colorectal Cancer (KANDLELIT-012)

Singapore, Aug. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-label, Multicenter Clinical Study to Evaluate the Safety and Efficacy ... Read More


Singapore Clinical Trial: A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, multi-center study, with a primary efficacy endpoint at 12 weeks, to determine the efficacy, safety, and tolerability of fixed doses of 15 mg bid and 30 mg bid of evenamide as add-on in patients with documented treatment-resistant schizophrenia, which is not adequately controlled by a stable therapeutic dose of the patient’s current antipsychotic medication(s).

Singapore, Aug. 21 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... Read More


Clinical Trial: Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as First Line Treatment in Metastatic Non-squamous RAS G12D-Mutated NSCLC

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777822) titled 'Study of Pembrolizumab + Pemetrexed + Platinum Chemotherapy With or Without Zoldonrasib as ... Read More


Clinical Trial: Magnesium Sulphate With Atropine and Pralidoxime vs Standard Therapy Alone in Acute Organophosphate Poisoning

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777835) titled 'Magnesium Sulphate With Atropine and Pralidoxime vs Standard Therapy Alone in Acute Organop... Read More


Clinical Trial: Time-restricted Eating and High-intensity Interval Training After Gestational Diabetes

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776886) titled 'Time-restricted Eating and High-intensity Interval Training After Gestational Diabetes' on ... Read More


Clinical Trial: Aging and Exercise Impacts on Glymphatic Function

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07775196) titled 'Aging and Exercise Impacts on Glymphatic Function' on Aug. 12. Brief Summary: This is a pr... Read More


Clinical Trial: Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07776080) titled 'Iparomlimab and Tuvonralimab With Lenvatinib, Radiotherapy, and HAIC for Hepatocellular Car... Read More


Clinical Trial: Evaluation of Non-Surgical Treatment of Breast Abscess

U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07777783) titled 'Evaluation of Non-Surgical Treatment of Breast Abscess' on Aug. 17. Brief Summary: Breast ... Read More